15280 Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials
Reich K, Strober B, Langley R, Song M, Shen Y, You Y, Foley P, Blauvelt A. 15280 Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials. Journal Of The American Academy Of Dermatology 2020, 83: ab145. DOI: 10.1016/j.jaad.2020.06.668.Peer-Reviewed Original Research